You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 158 No. 5, March 9, 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

The Obsolescence of Lactate Dehydrogenase Testing

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reference to lactate dehydrogenase (LDH) testing1 as a useful component of assessing probability of myocardial injury, it seems long past due that routine measurement of LDH isoenzymes be discouraged if not altogether abandoned. After more than 10 years of attempting to make LDH isoenzymes a sensitive and specific test with varying assays, it continues to fall short of any appropriate standard.

Given the typical use of this enzyme (assessing for myocardial injury after creatine kinase measurements have returned to baseline values), it has been proposed that LDH isoenzyme analysis be replaced by determination of cardiac-specific troponin I levels. Troponin I levels rise in a time course similar to creatine kinase isoenzyme MB, but remain elevated for 5 to 10 days. Recent data have shown troponin I to be specific in the setting of trauma,2 rhabdomyolysis,3 recent surgery,4 and renal failure (Greg S. Martin, MD, B.N. Becker, MD, and G. . . . [Full Text of this Article]







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.